Eisai licenses Nuvation lung cancer pill; Alnylam's stock dips after sales data report
Eisai licenses Nuvation lung cancer pill; Alnylam's stock dips after sales data report
Eisai licenses Nuvation lung cancer pill; Alnylam's stock dips after sales data report
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page